A5063269708- Prostate Cancer Diagnosis and Treatment
- Cervical Cancer and HPV Research
- Prostate Cancer Treatment and Research
- Global Cancer Incidence and Screening
- Health Systems, Economic Evaluations, Quality of Life
- Genetic factors in colorectal cancer
- Health disparities and outcomes
- Genital Health and Disease
- COVID-19 Pandemic Impacts
- Viral-associated cancers and disorders
- Colorectal Cancer Screening and Detection
- Adolescent Sexual and Reproductive Health
- HIV/AIDS Impact and Responses
- Poisoning and overdose treatments
- Global Health Care Issues
- Statistical Methods in Clinical Trials
- HIV/AIDS Research and Interventions
- Suicide and Self-Harm Studies
- Mental Health Treatment and Access
- Psychosomatic Disorders and Their Treatments
- Chronic Disease Management Strategies
- Posttraumatic Stress Disorder Research
- Electroconvulsive Therapy Studies
- Schizophrenia research and treatment
- HIV Research and Treatment
Ludwig-Maximilians-Universität München
2021-2024
University of Bern
2022-2024
Institute of Social and Preventive Medicine
2022-2024
LMU Klinikum
2024
Technical University of Munich
2021
Klinikum rechts der Isar
2021
München Klinik
2021
Abstract We followed adolescents and adults living with HIV aged older than 15 years who enrolled in a South African private-sector programme to examine adherence viral non-suppression (viral load > 400 copies/mL) of participants (20,743, 38%) without (33,635, 62%) mental health diagnoses. Mental diagnoses were associated unfavourable patterns. The risk was higher among patients organic disorders [adjusted ratio (aRR) 1.55, 95% confidence interval (CI) 1.22–1.96], substance use (aRR 1.53,...
Abstract Aims Prior research, largely focused on US male veterans, indicates an increased risk of cardiovascular disease among individuals with post-traumatic stress disorder (PTSD). Data from other settings and populations are scarce. The objective this study is to examine PTSD as a factor for incident major adverse events (MACEs) in South Africa. Methods We analysed reimbursement claims (2011–2020) cohort African medical insurance scheme beneficiaries aged 18 years or older. calculated...
People with mental illness have a reduced life expectancy, but the extent of mortality gap and contribution natural unnatural causes to excess among people in South Africa are unknown.
Several studies have found lower prostate cancer diagnosis rates among men with human immunodeficiency virus (HIV; MWH) than without HIV but reasons for this finding remain unclear.
Background: The increased prevalence of physical diseases among individuals with mental illness contributes to their risk mortality. However, the mediating role specific in effect on mortality is not well understood. Method: We conducted a longitudinal causal mediation analysis using data from beneficiaries South African medical insurance scheme 2011 2020. estimated overall major depressive disorder (MDD) and evaluated reductions this through hypothetical interventions risks an...
Although the total number of suicides decreased since beginning 1980s, suicide-related behaviors using self-intoxication increased. Therefore, research on characteristics individuals committing becomes growing importance for risk assessments and development preventive measures. In this prospective, observational, monocentric cohort study, all incoming calls at our Poisons Control Centre reporting through self-intoxication, were analyzed via a standardized questionnaire over 12 months. Both...
Background:The increased prevalence of physical diseases among individuals with mental illness contributes to their risk mortality. However, the mediating role specific in effect on mortality is not well understood. Method:We conducted a longitudinal causal mediation analysis using data from beneficiaries South African medical insurance scheme 2011-2020. We estimated overall major depressive disorder (MDD) and evaluated reductions this through hypothetical interventions risks an...
<p>Table S10 shows hazard ratios for prostate cancer diagnosis, restricting to men with at least one specific antigen test.</p>
<p>Table S6 shows rate ratios for prostate specific antigen (PSA) testing and biopsies, excluding HIV positive men not in Aid AIDS registration.</p>
<p>Hazard ratios for the association of different factors with an incident prostate cancer diagnosis.</p>
<p>Cohort characteristics by HIV status and overall.</p>
<div>AbstractBackground:<p>Several studies have found lower prostate cancer diagnosis rates among men with human immunodeficiency virus (HIV; MWH) than without HIV but reasons for this finding remain unclear.</p>Methods:<p>We used claims data from a South African private medical insurance scheme (July 2017– July 2020) to assess aged ≥ 18 years and HIV. Using flexible parametric survival models, we estimated hazard ratios (HR) the association between incident...
<p>Table S8 shows hazard ratios for prostate cancer diagnosis, excluding men with HIV without Aid AIDS registration.</p>
<p>Table S5 shows characteristics at diagnosis of prostate cancer, by population group.</p>
<p>Selection of study population. The flow diagram shows the number individuals who were excluded from analysis and reasons for exclusion.</p>
<div>AbstractBackground:<p>Several studies have found lower prostate cancer diagnosis rates among men with human immunodeficiency virus (HIV; MWH) than without HIV but reasons for this finding remain unclear.</p>Methods:<p>We used claims data from a South African private medical insurance scheme (July 2017– July 2020) to assess aged ≥ 18 years and HIV. Using flexible parametric survival models, we estimated hazard ratios (HR) the association between incident...
<p>Table S10 shows hazard ratios for prostate cancer diagnosis, restricting to men with at least one specific antigen test.</p>
<p>Table S6 shows rate ratios for prostate specific antigen (PSA) testing and biopsies, excluding HIV positive men not in Aid AIDS registration.</p>
<p>Table S4 shows characteristics at diagnosis of prostate cancer, by HIV status and overall.</p>
<p>Table S11 shows hazard ratios for prostate cancer diagnosis, restricting to men with an elevated specific antigen test result (>4 ng/mL) followed by a biopsy.</p>
<p>Rate or HR for PSA testing, prostate biopsies, biopsies in men with elevated PSA, and prostatitis diagnosis.</p>
<p>Table S7 shows rate ratios for prostate specific antigen testing (PSA) and biopsies, with no left-truncation at first HIV positive marker.</p>
<p>Table S8 shows hazard ratios for prostate cancer diagnosis, excluding men with HIV without Aid AIDS registration.</p>
<p>Selection of study population. The flow diagram shows the number individuals who were excluded from analysis and reasons for exclusion.</p>
<p>Prostate cancer diagnosis rates by age and HIV status. The figure shows estimated prostate per 100,000 person-years (years) among men with without HIV. shaded areas represent 95% CIs.</p>